NO20081131L - Stabilized protease composition - Google Patents

Stabilized protease composition

Info

Publication number
NO20081131L
NO20081131L NO20081131A NO20081131A NO20081131L NO 20081131 L NO20081131 L NO 20081131L NO 20081131 A NO20081131 A NO 20081131A NO 20081131 A NO20081131 A NO 20081131A NO 20081131 L NO20081131 L NO 20081131L
Authority
NO
Norway
Prior art keywords
composition
protease composition
stabilized protease
serine protease
stabilized
Prior art date
Application number
NO20081131A
Other languages
Norwegian (no)
Inventor
Hans Ageland
Lars-Olov Andersson
Original Assignee
Trobio Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/SE2005/001391 external-priority patent/WO2007035143A1/en
Application filed by Trobio Ab filed Critical Trobio Ab
Publication of NO20081131L publication Critical patent/NO20081131L/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Et preparat er angitt som omfatter en serinprotease; en reversibel inhibitor av nevnte serinprotease; og et stabiliserende middel M som har formel I. Det er også angitt anvendelse av preparatet som et medikament og andre anvendelser og metoder som benytter preparatets forskjellige egenskaper.A composition is indicated which comprises a serine protease; a reversible inhibitor of said serine protease; and a stabilizing agent M having formula I. The use of the composition as a medicament is also stated and other uses and methods utilizing the various properties of the composition.

NO20081131A 2005-09-22 2008-03-04 Stabilized protease composition NO20081131L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SE2005/001391 WO2007035143A1 (en) 2004-09-21 2005-09-22 Stabilized protease composition

Publications (1)

Publication Number Publication Date
NO20081131L true NO20081131L (en) 2008-06-18

Family

ID=39310896

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20081131A NO20081131L (en) 2005-09-22 2008-03-04 Stabilized protease composition

Country Status (4)

Country Link
JP (1) JP5080476B2 (en)
AU (1) AU2005336535B2 (en)
CA (1) CA2621059C (en)
NO (1) NO20081131L (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL229134A0 (en) * 2013-10-29 2014-03-31 Omrix Biopharmaceuticals Ltd Compounds and methods for stabilizing thrombin activity
CN116850977B (en) * 2023-07-28 2024-10-01 广州康盛生物科技股份有限公司 Directional coupling immunoadsorbent as well as preparation method and application thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW217410B (en) * 1992-04-01 1993-12-11 Ciba Geigy
GB9821483D0 (en) * 1998-10-03 1998-11-25 Glaxo Group Ltd Chemical compounds
EP1009758B1 (en) * 1997-08-29 2005-06-01 Tularik Limited Meta-benzamidine derivatives as serine protease inhibitors
JP3796340B2 (en) * 1997-11-18 2006-07-12 株式会社ノエビア Serine protease inhibitor
WO2002022575A1 (en) * 2000-09-11 2002-03-21 Genentech, Inc. Amidine inhibitors of serine proteases
US6713467B2 (en) * 2000-11-07 2004-03-30 Bristol-Myers Squibb Company Acid derivatives useful as serine protease inhibitors
GB0114005D0 (en) * 2001-06-08 2001-08-01 Glaxo Group Ltd Chemical compounds
US20040197852A1 (en) * 2001-08-09 2004-10-07 Shinataro Kamei Method of preparing peptide fragment having cell death inhibitory activity
JP2004191367A (en) * 2002-11-28 2004-07-08 Sysmex Corp Thrombin reagent and test reagent kit

Also Published As

Publication number Publication date
CA2621059C (en) 2013-08-13
AU2005336535B2 (en) 2012-05-24
JP2009508943A (en) 2009-03-05
JP5080476B2 (en) 2012-11-21
CA2621059A1 (en) 2007-03-29
AU2005336535A1 (en) 2007-03-29

Similar Documents

Publication Publication Date Title
NO20084069L (en) N formhylhydroksylamin compounds
RS51805B (en) Fungicidal compositions
CY1109911T1 (en) PYRROLOVENZODIAZEPINES
WO2007105058A8 (en) Pyrazole compounds
DK1487444T3 (en) Use of pyridylamides as angiogenesis inhibitors
EA200702670A1 (en) PREPARATION OF THYENOPYRIDINE INHIBITOR OF PLATELET AGGREGATION
NO20082346L (en) Hydrazone derivatives and uses thereof
NO20092710L (en) Cyclopaminanaloger
NO20082090L (en) Pyridopyrimidinone inhibitors of P13K alpha
BRPI0608886B8 (en) n-sulfonylpyrroles derivatives and their uses
RS53420B (en) Combinations of a macrocyclic quinoxaline compound which is an hcv ns3 protease inhibitor with other hcv agents
PT1940839E (en) Pyridopyrimidinone inhibitors of pi3kalpha
NO20063944L (en) Piperidinylcarbonyl-pyrrolidines and their use as melanocortin agonists
EA200970161A1 (en) DERIVATIVES 1 - (- D-GLYCOPHRANOSYL) -3- (4-CYCLOPROPYLPHENYLMETHYL) -4-HALOGENOINDOL AND THEIR APPLICATION AS SGLT INHIBITORS
NO20073791L (en) Pyrazolylaminopyridine derivatives useful as kinase inhibitors
NO20071549L (en) New benzofused heteroalrylsulfamide derivatives, useful as anticonvulsants
TW200833324A (en) Sulfonamide derivatives
NZ579928A (en) Fluorinated derivatives of deferiprone
MX2009008925A (en) Compounds of formula (i) as serine protease inhibitors.
DK1871374T3 (en) 2,3-substituted pyrazine sulfonamides as CRTH2 inhibitors
ATE553106T1 (en) HETEROARYLPYRROLOPYRIDINONES AS KINASE INHIBITORS
WO2007019191A3 (en) Thiazolopyrimidine kinase inhibitors
EA200801365A1 (en) SUBSTITUTED 5-PHENYL-3,6-DIGIDRO-2-OXO-6H-1,3,4-TIADIAZINS
NO20091353L (en) Serine hydrolase inhibitors
EA200801366A1 (en) DERIVATIVES 3,6-DIGIDRO-2-OXO-6N-1,3,4-TIADIAZINA

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application